Who owns APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) Institutional Ownership

Q: What is CUSIP 03835L306?

CUSIP 03835L306 is the security identifier used in SEC filing datasets for APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value.

CUSIP: 03835L306

13F Institutional Holders and Ownership History from Q1 2024 to Q1 2025

Type / Class: Equity / Common Stock, $0.001 par value
Symbol: APVO on Nasdaq
Shares outstanding: 2,864,322

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 03835L306?
CUSIP 03835L306 identifies APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 03835L306:

Q1 2025 (0 holders) Q4 2024 (0 holders) Q3 2024 (17 holders) Q2 2024 (18 holders) Q1 2024 (10 holders)

Significant Owners of Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
L1 Capital Global Opportunities Master Fund, Ltd.	7.6%	+23%		+$39,294	421,000	+110%	L1 Capital Global Opportunities Master Fund, Ltd.	21 Apr 2025
BIGGER CAPITAL FUND L P	10%	+62%			285,000	+42%	BIGGER CAPITAL FUND L P	18 Jun 2025

Institutional Holders of Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Price (Median)	Investors
2025 Q1	0	$0	-$8		0
2024 Q4	0	$0	-$231,143		0
2024 Q3	1,283,310	$231,143	-$296,003	$0.18	17
2024 Q2	1,963,743	$599,087	+$598,269	$0.31	18
2024 Q1	2,643	$12,395	+$12,395	$4.69	10